4 completed, 1 recruiting, 1 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow HPV Infection: new trials by email Literature Review of HPV Infection trials Research Report on HPV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years Placebo, 15-valent recombinant human papillomavirus vaccine (Hansenulapolymorpha) - HPV Infection, HPV-Related Carcinoma | Phase 1 | Unknown | Shanghai Bovax Biotechnology Co., Ltd. | 72 | 2024-08-03 | 2025-01-06 |
| Interferon Alpha Therapy for Cervical CINI and HPV Infection gel Interferon arm, gel Interferon and interferon suppository arm - Cervical Dysplasia, HPV Infection | Phase 1 | Completed | Mongolian National University of Medical Sciences | 60 | 2023-11-07 | 2025-04-03 |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women FluBHPVE6E7, Placebo - HPV Infection, HPV-Related Cervical Carcinoma | Phase 1 | Recruiting | BlueSky Immunotherapies GmbH | 20 | 2023-09-12 | 2025-02-14 |
| Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions ChAdOx1-HPV, MVA-HPV, Placebo - HPV Infection, CIN1 | Phase 1 / Phase 2 | Completed | Barinthus Biotherapeutics | 108 | 2021-03-16 | 2025-08-28 |
| Study of FluBHPVE6E7 in HPV-16 Infected Women FluBHPVE6E7 - HPV Infection | Phase 1 | Completed | BlueSky Immunotherapies GmbH | 28 | 2020-12-09 | 2023-06-26 |
| A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), Placebo - HPV Infection, HPV-Related Cervical Carcinoma | Phase 1 | Completed | National Vaccine and Serum Institute, China | 90 | 2019-09-07 | 2021-11-24 |
Papillomavirus Infections (6) · Condylomata Acuminata (1) · Uterine Cervical Dysplasia (1)
Communicable Diseases (6) · DNA Virus Infections (6) · Disease Attributes (6) · Genital Diseases (6) · Infections (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Sexually Transmitted Diseases (6) · Sexually Transmitted Diseases, Viral (6) · Tumor Virus Infections (6) · Urogenital Diseases (6) · Virus Diseases (6) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1)
BlueSky Immunotherapies GmbH (2) · Barinthus Biotherapeutics (1) · Mongolian National University of Medical Sciences (1) · National Vaccine and Serum Institute, China (1) · Shanghai Bovax Biotechnology Co., Ltd. (1)
China (2) · Austria (1) · Belgium (1) · Estonia (1) · Mongolia (1) · Slovakia (1) · United Kingdom (1)